Flex Pharma Inc (FLKS.OQ)
FLKS.OQ on NASDAQ Stock Exchange Global Market
0.51USD
17 Aug 2018
0.51USD
17 Aug 2018
Change (% chg)
$-0.02 (-3.77%)
$-0.02 (-3.77%)
Prev Close
$0.53
$0.53
Open
$0.53
$0.53
Day's High
$0.53
$0.53
Day's Low
$0.51
$0.51
Volume
53,354
53,354
Avg. Vol
54,983
54,983
52-wk High
$8.95
$8.95
52-wk Low
$0.51
$0.51
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jun '18 | 0.25 | -0.502 |
| Mar '18 | 0.18 | -0.460 | |
| FY 2017 | Dec '17 | 0.28 | -0.455 |
| Sep '17 | 0.41 | -0.537 | |
| Jun '17 | 0.34 | -0.514 | |
| Mar '17 | 0.24 | -0.490 | |
| FY 2016 | Dec '16 | 0.30 | -0.475 |
| Sep '16 | 0.60 | -0.650 | |
| Jun '16 | 0.11 | -0.706 | |
| Mar '16 | 0.00 | -0.605 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 2 | 0.28 | 0.36 | 0.20 | -- |
| Quarter Ending Dec-18 | 2 | 0.34 | 0.37 | 0.30 | -- |
| Year Ending Dec-18 | 2 | 1.08 | 1.27 | 0.90 | 6.18 |
| Year Ending Dec-19 | 2 | 3.61 | 5.60 | 1.61 | 28.62 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 2 | -0.21 | -0.17 | -0.25 | -- |
| Quarter Ending Dec-18 | 2 | -0.15 | -0.13 | -0.17 | -- |
| Year Ending Dec-18 | 2 | -1.27 | -1.23 | -1.32 | -2.55 |
| Year Ending Dec-19 | 2 | -0.43 | -0.31 | -0.55 | -2.52 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 99.36 | 30.45 | |
| P/E High - Last 5 Yrs. | -- | 272.05 | 47.36 | |
| P/E Low - Last 5 Yrs. | -- | 95.21 | 24.74 | |
| Beta | 2.76 | 0.78 | 0.84 | |
| Price to Sales (TTM) | 8.22 | 126.22 | 5.98 | |
| Price to Book (MRQ) | 0.69 | 13.00 | 3.69 | |
| Price to Tangible Book (MRQ) | 0.69 | 22.28 | 5.63 | |
| Price to Cash Flow (TTM) | -- | 64.21 | 20.97 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.37 | 1.78 | |
| Dividend Yield - 5 Year Avg | -- | 0.21 | 1.46 | |
| Dividend 5 Year Growth Rate | -- | 2.47 | -5.93 | |
| Payout Ratio(TTM) | -- | 6.14 | 46.55 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -26.83 | 158.89 | 7.18 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -24.09 | 91.20 | 12.05 | |
| Sales - 5 Yr. Growth Rate | -- | 24.34 | 7.61 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 2.36 | 74.27 | 23.85 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 8.28 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 23.23 | 7.52 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 36.95 | 8.06 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 4.38 | 1.73 | 2.50 |
| Current Ratio (MRQ) | 4.46 | 5.42 | 3.53 |
| LT Debt to Equity (MRQ) | 0.00 | 19.75 | 11.27 |
| Total Debt to Equity (MRQ) | 0.00 | 23.48 | 14.23 |
| Interest Coverage (TTM) | -- | -186.89 | 31.77 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 51.27 | 57.13 | 55.23 | |
| Gross Margin - 5 Yr. Avg. | -- | 52.64 | 53.33 | |
| EBITD Margin (TTM) | -3,006.98 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -189.34 | 15.82 | |
| Operating Margin (TTM) | -3,113.66 | -673.76 | 3.86 | |
| Operating Margin - 5 Yr. Avg. | -- | -202.74 | 10.95 | |
| Pre-Tax Margin (TTM) | -3,091.07 | -665.74 | 4.16 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -203.67 | 11.12 | |
| Net Profit Margin (TTM) | -3,091.07 | -655.99 | 0.98 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -201.27 | 7.47 | |
| Effective Tax Rate (TTM) | -- | 12.18 | 20.36 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.69 | 24.15 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 56,026 | 5,071,848 | 718,909,906 | |
| Net Income/Employee (TTM) | -1,731,787 | -6,208,777 | 83,624,743 | |
| Receivable Turnover (TTM) | 43.04 | 6.39 | 5.38 | |
| Inventory Turnover (TTM) | 1.13 | 2.25 | 3.51 | |
| Asset Turnover (TTM) | 0.03 | 0.42 | 0.83 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -103.63 | 1.88 | 10.04 | |
| Return on Assets - 5 Yr. Avg. | -- | 2.31 | 10.94 | |
| Return on Investment (TTM) | -119.40 | 2.89 | 12.63 | |
| Return on Investment - 5 Yr. Avg. | -- | 1.68 | 14.14 | |
| Return on Equity (TTM) | -119.61 | 1.65 | 14.82 | |
| Return on Equity - 5 Yr. Avg. | -- | -6.94 | 15.50 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 26.11 | -- | -- |
| EPS (TTM) % | 18.00 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Flex Pharma Inc
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- Flex Pharma to scrap two mid-stage neuromuscular disease trials
- UPDATE 1-Flex Pharma to scrap two mid-stage neuromuscular disease trials
- Flex Pharma to cut 60 percent of workforce
- BRIEF-Flex Pharma Reports Q1 Loss Per Share $0.46
- BRIEF-Flex Pharma Reports Positive Topline Data From Exploratory Phase 2 Trial Of FLX-787 In Multiple Sclerosis
Institutional Holders
| % Shares Owned: | 33.76% |
| # of Holders: | 40 |
| Total Shares Held: | 6,099,650 |
| 3 Mo. Net Change: | -2,137,743 |
| # New Positions: | 6 |
| # Closed Positions: | 12 |
| # Increased Positions: | 16 |
| # Reduced Positions: | 19 |
| # Net Buyers: | -3 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.